FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/100391 [Registered on: 06/01/2026] Trial Registered Prospectively
Last Modified On: 06/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Non-randomized, Active Controlled Trial 
Public Title of Study   Revolutionizing Implant Loading: Prospective Clinical Trial in Partially Edentulous Patients. 
Scientific Title of Study   Pioneering Immediate loading in tissue and bone level implants- A prospective clinical trial across diverse patient profiles in partially edentulous ridges. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Anshul Trivedi 
Designation  Associate professor 
Affiliation  Subharti Dental College and Hospital, Swami vivekanand University , Meerut 
Address  Room no - 6 Department of Prosthodontics & Crown and Bridge, Subharti Dental College and hospital, Subhartipuram, Meerut

Meerut
UTTAR PRADESH
250005
India 
Phone  9012694104  
Fax    
Email  dranshulmsaxena@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anshul Trivedi 
Designation  Associate professor 
Affiliation  subharti dental college and hospital, swami vivekanand university, Meerut 
Address  Room no - 6 Department of Prosthodontics & Crown and Bridge, Subharti Dental College and hospital, Swami Vivelanand University,Subhartipuram, Meerut.

Meerut
UTTAR PRADESH
250005
India 
Phone  9012694104  
Fax    
Email  dranshulmsaxena@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Anshul Trivedi 
Designation  Associate professor 
Affiliation  subharti dental college and hospital, meerut 
Address  Room no - 6 Department of Prosthodontics & Crown and Bridge, Subharti Dental College and hospital, Subhartipuram, Meerut

Meerut
UTTAR PRADESH
250005
India 
Phone  9012694104  
Fax    
Email  dranshulmsaxena@gmail.com  
 
Source of Monetary or Material Support  
No support 
 
Primary Sponsor  
Name  Dr Sweta 
Address  Swami Vivekanand Subharti University, Subharti Dental College and Hospital, Meerut. 
Type of Sponsor  Other [for my research study(thesis) , I am the primary sponsor here(Self)] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sweta  Subharti Dental College and Hospital,Meerut  Department of Prosthodontics & crown and bridge, Room number 6, PG section, Swami Vivekanand Subharti University,Subharti Dental College and Hospital, Subhartipuram, Meerut
Meerut
UTTAR PRADESH 
07249915010

teotiasweta2900@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
University Ethics Committee(Medical) Swami Vivekanand Subharti University  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E00-E07||Disorders of thyroid gland, (2) ICD-10 Condition: I10||Essential (primary) hypertension, (3) ICD-10 Condition: E119||Type 2 diabetes mellitus without complications,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Immediate loading in bone level and tissue level implant  Bone and Tissue level implants will be placed in partially edentulous ridges particularly in medically compromised patients followed by immediate loading. After an optimum osseointegration period of 3-4 months, definitive prosthesis will be delivered. Follow up readings will be taken up - Baseline readings, at the end of 3rd month interval, 6th month interval and one year interval. 
Comparator Agent  Tissue level and Bone level implants  Tissue level and bone level implants will be placed in partially edentulous ridges particularly in medically compromised patients followed by immediate loading. After an optimum osseointegration periodof 3-4 months, definitive prosthesis will be delivered. Follow up readings will be taken up - Baseline readings, at the end of 3rd month interval, 6th month interval and one year interval. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  INCLUSION CRITERIA

1)Age : 18-75 years
2)Patient willing for procedure (the study is explained, including the procedure and followup for evaluation)
3)Partially edentulous patients indicated replacement with an implant.
4)Patient presents with controlled diabetes/hypertension
5)Implant site free from infection
6)Adequate mouth opening
7) Sufficient bone volume for placing implants
8)Implants should be placed at healed sites. 
 
ExclusionCriteria 
Details 
EXCLUSION CRITERIA

1.Insufficient bone quality
2. Inadequate mouth opening
3. Heavy smokers
4. Chronic alcoholic
5. Presence of vital anatomical structures close to the implant site
6. Patient under immunosuppressive therapy or radiotherapy
7. Psychiatric disorders
8. Disorders to the implant site related to a history
of radiation therapy to the head and neck, or bone augmentation.
9.Recent myocardial infarction or cerebrovascular accident, ongoing chemotherapy treatment, intravenous anti-angiogenic agents use
10.Untreated bleeding issues
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Other 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Evaluation of radiological, biological, and prosthetic outcomes of immediate loading in tissue and bone level implants.
1. Width of keratinised gingiva
2. IOPA with grid and cbct to measure crestal bone loss
3. incidence, frequency, onset of screw loosening 

1. width of keratinised gingiva will be assessed at 3rd month interval, 6th month interval and at the end of one year interval.

2.IOPA with Grid to measure crestal bone loss will be assessed at 3rd month ,6th month , and at the end of one year interval.
3.Incidence/ Frequency /onset of screw loosening at 3, 6 and 1 year interval 
 
Secondary Outcome  
Outcome  TimePoints 
1.Crestal Bone Loss: Assessing the amount of crestal bone loss around the implants at various follow-up intervals.
2.Width of Keratinized Mucosa: Measuring the width of keratinized mucosa at the implant site, specifically at the mid-buccal aspect of each implant.
3.Incidence, Frequency & onset of screw loosening
 
1.3rd month interval, 6th month interval & at the end of one year interval.

2. at 3rd month ,6th month , & at the end of one year interval.
3.At 3rd,6th, & one year interval. 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   22/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  22/01/2026 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This prospective clinical trial aims to evaluate the clinical efficacy and outcomes of immediate loading in tissue and bone level implants among patients with partially edentulous ridges at Subharti Dental College and Hospital in Meerut. By assessing radiological, biological, and prosthetic parameters, the study seeks to understand implant performance in patients with systemic conditions such as diabetes and hypertension. With a sample size of 20 implants, equally divided between tissue and bone level types, the research hypothesizes that tissue level implants will show better soft tissue integration and lower crestal bone loss compared to bone level implants. The results aim to enhance clinical decision-making and improve patient care in medically compromised populations over a two-year period. 
Close